RAC 2.73% $1.61 race oncology ltd

Ann: Bisantrene Phase 2 AML Trial Successful Concludes, page-9

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 134 Posts.
    lightbulb Created with Sketch. 57
    Been on the side-lines for a little while now due to some personal reasons but very happy to say I'm back on board after this announcement.

    Was always nervous that this was going to take off without me, thankfully it's still a sleeping giant...

    Great announcement that can only have one feeling more confident in an already amazing drug.

 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.